Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lactitol 10g oral powder sachets
0106040F0AAAAAA
|
Lactitol | Lactitol | Gastro-Intestinal System | No data available |
|
Lactugal 3.1-3.7g/5ml oral solution
0106040G0BEAAAA
|
Lactugal | Lactulose | Gastro-Intestinal System | No data available |
|
Lanes Modern Herbals Laxative tablets
010602000BBBIA0
|
Proprietary compound preparation BNF 0106020 | Other stimulant laxative preparations | Gastro-Intestinal System | No data available |
|
Lansoprazole 10mg oral powder sachets
0103050L0AAARAR
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 11mg/5ml oral liquid
0103050L0AAAUAU
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 15mg oral powder sachets
0103050L0AABBBB
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 20mg/5ml oral liquid
0103050L0AAASAS
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 22.5mg/5ml oral suspension
0103050L0AABABA
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 22mg/5ml oral liquid
0103050L0AAAVAV
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 3.75mg/5ml oral solution
0103050L0AABDBD
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 30mg gastro-resistant granules sachets
0103050L0AAADAD
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 3mg/5ml oral liquid
0103050L0AAAKAK
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 40mg/5ml oral liquid
0103050L0AAATAT
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 4mg/5ml oral liquid
0103050L0AAAPAP
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 50mg/5ml oral suspension
0103050L0AAAWAW
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 5mg/5ml oral solution
0103050L0AAAQAQ
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 60mg/5ml oral liquid
0103050L0AAALAL
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 7.5mg/5ml oral liquid
0103050L0AAANAN
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 8mg/5ml oral suspension
0103050L0AABCBC
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lauromacrogol 400 5% / Heparinoid 0.2% rectal ointment
0107010J0AAABAB
|
Lauromacrogol/ Heparinoid | Heparinoid | Gastro-Intestinal System | No data available |
|
Lauromacrogol 400 50mg / Heparinoid 4mg suppositories
0107010J0AAAAAA
|
Lauromacrogol/ Heparinoid | Heparinoid | Gastro-Intestinal System | No data available |
|
Laxagol oral powder sachets
0106040M0BEAAAA
|
Laxagol | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Lemlax 3.26g/5ml oral solution
0106040G0BHAAAA
|
Lemlax | Lactulose | Gastro-Intestinal System | No data available |
|
Librax capsules
0102000D0BHABAH
|
Librax | Compound antispasmodic preparations | Gastro-Intestinal System | No data available |
|
Liq paraffin / Magnesium hydroxide emulsn sugar free
0106040J0AAAFAF
|
Magnesium hydroxide (Laxative) | Magnesium hydroxide | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.